| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1471-4159.1974.TB11589.X |
| P698 | PubMed publication ID | 4829953 |
| P2093 | author name string | Miller RJ | |
| Cuello AC | |||
| Horn AS | |||
| P2860 | cites work | Role of the tuberculum olfactorium in stereotyped behaviour induced by apomorphine in the rat | Q28249465 |
| A protein binding assay for adenosine 3':5'-cyclic monophosphate | Q33703192 | ||
| Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". | Q34721196 | ||
| Catecholamines in the brain as mediators of amphetamine psychosis | Q39895896 | ||
| Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action | Q41521409 | ||
| Dopamine receptor blockade--a central action of chlorpromazine on striatal neurones. | Q42439044 | ||
| Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues | Q42440301 | ||
| Catecholamines in the Median Eminence: New Evidence for a Major Noradrenergic Input | Q48650985 | ||
| Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines | Q48706445 | ||
| Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs | Q48777635 | ||
| Evidence for dopamine receptor stimulation by apomorphine. | Q51208002 | ||
| The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat | Q52734754 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 265-270 | |
| P577 | publication date | 1974-02-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity | |
| P478 | volume | 22 |
| Q36096694 | 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms |
| Q40688370 | A common uptake system for serotonin and dopamine in human platelets |
| Q28643908 | A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions |
| Q67369785 | A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain |
| Q39995099 | A noradrenaline sensitive adenylate cyclase in the rat limbic forebrain: Preparation, properties and the effects of agonists, adrenolytics and neuroleptic drugs |
| Q48497944 | Adenosine 3',5'-monophosphate content in rat caudate nucleus: demonstration of dopaminergic and adrenergic receptors |
| Q40287147 | Adenosine 3′:5′-monophosphate-dependent in vitro phosphorylation of synaptosomal membrane proteins from rat corpus striatum following systemic administration of L-DOPA and bromocriptine |
| Q38034570 | Agents acting on central dopamine receptors |
| Q48440490 | Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum |
| Q21262022 | Amphetamine and pseudoephedrine cross-tolerance measured by c-Fos protein expression in brains of chronically treated rats |
| Q67438774 | Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine |
| Q37796814 | Anti-schizophrenic drugs—Membrane receptor sites of action |
| Q39099099 | Antipsychotic phenothiazine drugs and the significance of the X-ray structure of promazine HCl |
| Q48464808 | Behavioral effects of local injection of 6-hydroxydopamine in the medial ventral tegmentum in the rat. Possible role of the mesolimbic dopaminergic system |
| Q49090583 | Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei |
| Q67300699 | Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine |
| Q40321828 | Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics |
| Q48189119 | Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function |
| Q48472816 | Brain and caudate nucleus adenylate cyclase: Effects of dopamine, GTP, E prostaglandins and morphine |
| Q72441854 | Brain neurotransmitter system and chronic lead intoxication |
| Q40680008 | Catecholamine innervation of the basal forebrain III. Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex |
| Q39644746 | Catecholamine-sensitive adenylate cyclases in nervous tissues |
| Q39776943 | Catecholamines and self-stimulation: Evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine |
| Q48455421 | Catecholamines and self-stimulation: pharmacological differences between near- and far-lateral hypothalamic sites |
| Q70937224 | Changes in catecholamine neuronal uptake and receptor binding in the brains of spontaneously hypertensive rats (SHR) |
| Q43771109 | Changes in mesocorticolimbic dopamine and D1/D2 receptor levels after low level lead exposure: a time course study |
| Q40327133 | Characterization of a dopamine-sensitive adenylate cyclase in the rat caudate nucleus |
| Q71716629 | Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS |
| Q43632484 | Chronic low-dose haloperidol effects on self-stimulation rate-intensity functions |
| Q36097007 | Clonidine distribution in the rat: temporal relationship between tissue levels and blood pressure response |
| Q48151629 | Clozapine decreases neuropeptide Y-like immunoreactivity and neuropeptide Y mRNA levels in rat nucleus accumbens |
| Q51743119 | Cocaine produces locomotor stimulation in SS but not LS mice: relationship to dopaminergic function. |
| Q45095406 | Cocaine produces low dose locomotor depressant effects in mice |
| Q66986022 | Comparison of dopamine synthesis regulation in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons |
| Q45769870 | Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions |
| Q48477284 | Determination of nanogram amounts of homovanillic acid in the central nervous system with a rapid semiautomated fluorometric method |
| Q66939988 | Determination of picogram levels of brain serotonin by a simplified liquid chromatographic electrochemical detection assay |
| Q39123377 | Dexclamol: Effects on catecholamine metabolism and demonstration of stereochemical specificity of antagonism of central adrenergic receptors |
| Q67452664 | Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum |
| Q49153271 | Differential effects of (+)-amphetamine, methylphenidate, and amfonelic acid on catecholamine synthesis in selected regions of the rat brain |
| Q43785656 | Differential effects of d- and l-propranolol on dopamine turnover stimulated by oxotremorine in striatal and mesolimbic areas of rat brain |
| Q48244802 | Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration |
| Q44189362 | Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration |
| Q39205258 | Direct effect of a nomifensine derivative on dopamine receptors |
| Q39251718 | Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra |
| Q66986017 | Dopa accumulation is a measure of dopamine synthesis in the median eminence and posterior pituitary |
| Q69000263 | Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain |
| Q39078920 | Dopamine Receptors in the Brain |
| Q48411487 | Dopamine agonist-induced stereotypic grooming and self-mutilation following striatal dopamine depletion |
| Q48445388 | Dopamine and norepinephrine levels in the nucleus accumbens, olfactory tubercle and corpus striatum following lesions in the ventral tegmental area |
| Q66706106 | Dopamine and schizophrenia |
| Q41648418 | Dopamine metabolism and receptor function after acute and chronic ethanol |
| Q48440108 | Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol |
| Q40334162 | Dopamine receptor blockade and the neuroleptics, a crystallographic study |
| Q48243762 | Dopamine receptor sensitivity in brain and retina of rats during aging |
| Q36992794 | Dopamine receptors and sleep induction in man |
| Q39160956 | Dopamine receptors in rat striatum and nucleus accumbens; conformational studies using rigid analogues of dopamine |
| Q40190461 | Dopamine receptors in the central thermoregulatory pathways of the rat |
| Q40004311 | Dopamine-Sensitive Adenylate Cyclase Occurs in a Region of Substantia Nigra Containing Dopaminergic Dendrites |
| Q48460703 | Dopamine-like effects of cholera toxin in the central nervous system |
| Q39917087 | Effect of butaclamol and its enantiomers upon striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats |
| Q40327303 | Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum |
| Q40921049 | Effect of haloperidol and d-amphetamine on cerebral tyramine and octopamine levels |
| Q48246553 | Effect of morphine on dopamine-sensitive adenylate cyclase activity of nucleus accumbens |
| Q67298475 | Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as drug for the elderly |
| Q48260725 | Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat. |
| Q67832575 | Effects of ageing on the content in sulfur-containing amino acids in rat brain |
| Q48965246 | Effects of amantadine on dopaminergic neurons in discrete regions of the rat brain |
| Q66961741 | Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats |
| Q39182847 | Effects of bromocriptine on adenylate cyclase and phosphodiesterase activities of rat striatum |
| Q39082676 | Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity |
| Q48538541 | Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography |
| Q44361744 | Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants |
| Q48626391 | Effects of morphine on dopamine metabolism in rat striatum and limbic structures in relation to the activity of dopaminergic neurones |
| Q43764321 | Effects of psychological stress on monoamine systems in subregions of the frontal cortex and nucleus accumbens of the rat. |
| Q39209458 | Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties |
| Q41537141 | Electrophysiological responses of neurones in the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system |
| Q67342377 | Enhancement of apomorphine-induced inhibition of vocalisation afterdischarge response by theophylline |
| Q35128079 | Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity |
| Q40325029 | Enzymatic evidence for a meso-limbic dopaminergic innervation in the olfactory tubercle of the rabbit |
| Q44063639 | Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart |
| Q70911665 | Gas chromatographic determination of some biogenic amines as their pentafluorobenzoyl derivatives in the picogram range and its applicability to biological materials |
| Q39156108 | Guanylate cyclase activity in various rat brain areas |
| Q38789379 | Heterogeneous extracellular dopamine regulation in the subregions of the olfactory tubercle. |
| Q72421023 | In vivo blockade of dopaminergic receptors from different rat brain regions by classical and atypical neuroleptics |
| Q51720769 | Inbred rat strain comparisons indicate different sites of action for cocaine and amphetamine locomotor stimulant effects |
| Q67269267 | Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions |
| Q40164529 | Increase in dopamine in cerebral cortex and other regions of rat brain after microwave fixation: possible diffusion artifact |
| Q39743126 | Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain |
| Q52248666 | Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. |
| Q48333613 | Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum |
| Q66898486 | Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat |
| Q41733960 | Interaction of sulpiride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo |
| Q49092294 | Interactions of a neuroleptic drug (fluphenazine) with catecholamines in hippocampus |
| Q35028210 | L-3,4-dihydroxyphenylalanine-induced hypersensitivity simulating features of denervation |
| Q39936303 | LSD and dopamine-sensitive adenylate-cyclase in various rat brain areas |
| Q66921709 | Lack of a high affinity transport system for dopamine in the median eminence and posterior pituitary |
| Q48387620 | Lesions of ascending dopaminergic pathways decrease forebrain glucose uptake |
| Q40652109 | Localization of GABAergic, cholinergic and aminergic structures in the mesolimbic system |
| Q39149367 | Localization of Nigral Dopamine-Sensitive Adenylate Cyclase on Neurons Originating from the Corpus Striatum |
| Q39099094 | Localization of dopamine receptors in the rat cerebral cortex |
| Q41690441 | Localization of glutamic acid decarboxylase within laminae of the rat olfactory tubercle |
| Q40348571 | Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine |
| Q48679942 | Manipulation of mobile phase parameters for the HPLC separation of endogenous monoamines in rat brain tissue |
| Q41359421 | Mesolimbic dopamine neurons: Effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats |
| Q39298281 | Mesolimbic dopaminergic neurones and somatodendritic mechanisms |
| Q44263622 | Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function |
| Q71512333 | Morphine differentially alters synthesis and turnover of dopamine in central neuronal systems |
| Q48198822 | Motor activity of rats following intracerebral injections of drugs influencing GABA mechanisms |
| Q66959814 | Muscarinic cholinergic binding in striatal and mesolimbic areas of the rat: Reduction by 6-hydroxydopa |
| Q39673815 | Naloxone antagonizes theophylline-induced potentiation of morphine inhibition of a nociceptive reaction in rats |
| Q48882530 | Neurochemical Studies of the Mesolimbic Dopaminergic Pathway: [3H]Spiperone Labels Two Binding Sites in Homogenates of the Nucleus Accumbens of Rat Brain |
| Q66706108 | Neuromuscular transmission in asthma |
| Q66898482 | Nomifensine: A potent dopaminergic agonist of antiparkinson potential |
| Q48646647 | Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens |
| Q67440453 | Norepinephrine-epinephrine and serotonin content of nasal mucosa in relation to hemorrhage, reserpine and excitement |
| Q40118821 | Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous system |
| Q48260989 | Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis |
| Q66852521 | On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain |
| Q40031471 | On the structural requirements for dopamine-like activity in homogenates of rat nucleus accumbens [proceedings] |
| Q40030053 | Ontogenesis of the multiple forms of choline acetyltransferase: uptake and acetylation of choline in rat brain [proceedings] |
| Q48371944 | Ontogenetic development of neostriatal dopamine receptors in the rat. |
| Q39773343 | Pharmacology and Neurochemistry of Apomorphine |
| Q28138954 | Psychopharmacological studies on (-)-nuciferine and its Hofmann degradation product atherosperminine |
| Q35013822 | Quantitative correlation of dopamine-dependent adenylate cyclase with responses to levodopa in various mice |
| Q64986355 | Rat climbing behavior elicited by stimulation of cerebral dopamine receptors. |
| Q48830098 | Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay |
| Q39159387 | Regional effects of neuroleptics of dopamine metabolism and dopamine-sensitive adenylate cyclase activity |
| Q39212809 | Regional localization of halopemide, a new psychotropic agent, in the rat brain |
| Q39128853 | Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa |
| Q48941510 | Species Differences in the Brain Regional Distribution of Receptor Binding for Thyrotropin-Releasing Hormone |
| Q40047537 | Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals |
| Q43828208 | Stereoselective effects of the potentially neuroleptic rigid spiro amines |
| Q39096659 | Stimulation of tyrosine hydroxylase activity by cyclic amp in synaptosomes and in soluble striatal enzyme preparations |
| Q40161727 | Structural and steric requirements for ?-phenethylamines as agonists of the noradrenergic cyclic AMP generating system in the rat limbic forebrain |
| Q39999834 | Studies on the behavioural pharmacology of a cyclic analogue of dopamine following its injection into the brains of conscious rats |
| Q48382598 | Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase |
| Q39969560 | Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain |
| Q38003131 | The Formation, Degradation, and Function of Cyclic Nucleotides in the Nervous System |
| Q37369100 | The Role of Cyclic Nucleotides in the CNS |
| Q40229404 | The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions |
| Q48529559 | The conformation of dopamine at its uptake site; further studies with rigid analogues |
| Q39999711 | The interaction of neuroleptic and muscarinic agents with central dopaminergic systems |
| Q39104562 | The nature of receptors regulating the formation of cyclic AMP in brain tissue |
| Q41034664 | The nucleus accumbens–possible site of antipsychotic action of neuroleptic drugs? |
| Q39278128 | The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: Metoclopramide, thiethylperazine, and molindone as pharmacological tools |
| Q28339708 | Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients |
| Q71578698 | Type A monoamine oxidase catalyzes the intraneuronal deamination of dopamine within nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons in the rat |
| Q44761069 | Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats |
| Q49830688 | iTRAQ-based quantitative proteomic analysis reveals important metabolic pathways for arsenic-induced liver fibrosis in rats. |
Search more.